The Relationship Between an AI System's Intended Purpose
and Risk Management
under the EU AI Act

Under the EU AI Act, the intended purpose of an AI system is the cornerstone of risk management. Article 3(12) defines intended purpose as "the use for which an AI system is intended by the provider, including the specific context and conditions of use, as specified, implied or made known through information provided by the provider in the instructions for use, promotional or sales materials and statements, as well as in the technical documentation." This definition directly shapes the scope, depth, and execution of the mandatory risk management system (Article 9) - determining which risks must be identified, evaluated, mitigated, and monitored. This article articulates the critical relationship between intended purpose and risk management from regulatory, operational, practical, and strategic perspectives, with examples, edge cases, and implications for high-risk AI providers.

Regulatory Foundation: Why Intended Purpose Is the Anchor of Risk Management

Article 9(2)(a) explicitly requires the risk management system to identify and analyse 'the known and foreseeable risks to health, safety and fundamental rights associated with the intended purpose and reasonably foreseeable misuse' of the high-risk AI system. The intended purpose therefore serves as:

• The Scope Boundary: Only risks linked to the intended purpose (and foreseeable misuse) fall within the mandatory risk management obligation.
• The Context Driver: The specific use case, users, environment, and conditions of use determine which rights and harms are relevant.
• The Compliance Reference Point: All downstream obligations (data governance, human oversight, robustness, post-market monitoring, technical documentation) are calibrated to the intended purpose.
• The Change Trigger: Any substantial modification that alters the intended purpose triggers re-assessment of classification (Article 6) and full re-application of risk management and conformity assessment.

Misalignment between stated intended purpose and actual use (or failure to document foreseeable misuse) creates significant compliance risk - authorities can re-interpret the system's purpose during market surveillance, potentially re-classifying it as high-risk or imposing retroactive obligations.

How Intended Purpose Shapes Risk Management in Practice

The intended purpose is operationalised through a structured, documented process that directly influences every step of risk management:

• Definition & Documentation: The provider must clearly articulate the intended purpose in instructions for use, promotional materials, technical documentation (Annex IV), and QMS records - including specific context, users, conditions, and limitations.
• Risk Identification: Risks are scoped to the stated purpose and reasonably foreseeable misuse (e.g., using a medical diagnostic AI outside its intended clinical population triggers additional risks not originally assessed).
• Risk Evaluation & Mitigation: Severity and likelihood are assessed within the intended context; mitigations (e.g., human oversight, transparency measures) are tailored to the defined use case.
• Post-Market Monitoring Calibration: Monitoring parameters (KPIs, thresholds, data sources) are set based on the intended purpose and anticipated real-world deviations.
• Change Control Linkage: Any change that materially affects the intended purpose requires re-evaluation of risk management and potentially re-classification/conformity assessment.

Practical example: An AI system intended for 'assisting radiologists in detecting lung nodules on CT scans' (narrow diagnostic support role) has a very different risk profile than the same algorithm re-purposed for 'autonomous screening and triage without radiologist review.' The first requires risk management focused on augmentation errors and human oversight effectiveness; the second triggers far broader risks (misdiagnosis, delayed treatment, liability shifts) and potentially re-classification as higher-risk - necessitating a substantial modification process.

Edge Cases and Nuances in the Intended Purpose�Risk Management Relationship

Key edge cases:

• Reasonably foreseeable misuse: Even if outside stated purpose, foreseeable misuse (e.g., using a hiring AI for discriminatory profiling despite stated non-discrimination commitment) must be assessed and mitigated.
• Scope creep / mission drift: Gradual expansion of use (e.g., from internal analytics to customer-facing decisions) can trigger re-assessment if it materially changes the intended purpose.
• General-purpose AI downstream: When a GPAI model is integrated into a high-risk system, the downstream provider defines the intended purpose for that specific application - triggering full risk management obligations for that use case.
• Continuously learning systems: The intended purpose must include boundaries of adaptation (e.g., 'learning within predefined clinical guidelines'); exceeding these boundaries may constitute a change of purpose requiring re-assessment.

Nuance: Providers often under-document intended purpose, leading to disputes during audits. Best practice is to define it precisely, with limitations and exclusions, and maintain version-controlled records of any clarifications or updates.

Integration, Strategic Implications, and Link to EN 18286

EN 18286 embeds the intended purpose as a foundational input across the QMS: it shapes risk management planning (Clause 6), product realisation processes (Clause 8), post-market monitoring scope, and audit criteria. The standard's lifecycle-centric approach ensures that every QMS element is calibrated to the documented intended purpose - from design controls to change management.

Strategic implications: A clearly defined, well-documented intended purpose minimises regulatory exposure (limits scope of mandatory risk management), enables proportionate compliance, and provides a defensible reference point in audits or litigation. Conversely, vague or overly broad purpose statements can inadvertently expand obligations or create enforcement vulnerabilities. Best practice: Define intended purpose early and precisely, review it during design reviews and substantial modifications, document foreseeable misuse explicitly, integrate it into QMS training and audit programmes, and align with EN 18286 draft requirements for future-proofing.

In summary, under the EU AI Act the intended purpose is the defining lens through which risk management is scoped, executed, and maintained. It determines which risks must be addressed, how mitigation is prioritised, and when re-assessment is triggered - ensuring that the risk management system remains relevant, proportionate, and effective throughout the AI system's life cycle. EN 18286 reinforces this relationship by embedding the intended purpose as a central organising principle of the Quality Management System, achieving coherent, auditable, and rights-protecting AI governance.

Content based on the EU AI Act (Regulation (EU) 2024/1689), Articles 3(12), 9 & 17, and the EN 18286 draft standard. The standard remains under revision; always consult the latest CEN/CENELEC drafts, EU AI Office guidance, and legal experts for implementation. High-risk provisions become fully applicable on 2 August 2026.